Immediate Impact

2 by Nobel laureates 19 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
2023 Standout
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout

Works of David L. Graham being referenced

Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
2021
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
2017

Author Peers

Author Last Decade Papers Cites
David L. Graham 411 588 538 590 91 2.9k
Christopher J. Williams 602 321 1120 629 122 4.3k
David J. Lynn 290 353 499 2200 95 4.9k
Michal Mandelboim 361 256 1220 1006 155 4.8k
Markus Eickmann 207 357 920 564 73 4.0k
Qian Wang 387 443 338 955 117 4.6k
George Sourvinos 779 513 1103 1198 136 4.0k
Shelley J. Newman 291 643 268 226 108 2.5k
Margreet Bakker 211 322 999 722 126 4.6k
Yang Pan 714 458 598 875 128 4.9k
Yaping Chen 592 208 536 978 179 3.7k

All Works

Loading papers...

Rankless by CCL
2026